Form 4: USANA Health Sciences CFO Reports Stock Transactions

G. Doug Iieking, CFO of USANA Health Sciences, reports the acquisition and disposal of common stock and restricted stock units on February 8, 2025.

Summary

• On February 8, 2025, G. Doug Iieking, the Chief Financial Officer of USANA Health Sciences, executed transactions involving the company's stock.
• Iieking acquired 2,322 shares of common stock through the vesting of restricted stock units.
• Iieking disposed of 1,564 shares of common stock at a price of $30.65.
• Iieking also acquired 4,085 shares of common stock through the vesting of restricted stock units.
• A further disposal of 2,752 shares of common stock occurred at a price of $30.65.
• Following these transactions, Iieking directly owns 4,548 shares of common stock.
• Iieking also holds 25,634 restricted stock units that vest 25% on the anniversary of February 8th, 2021.
• Iieking holds 21,549 restricted stock units that vest 25% on the anniversary of February 8th, 2024.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions by a company insider, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to the market.

Stakeholder Impact

• Shareholders are informed about the CFO's transactions in company stock, providing insight into management's perspective.

Key Dates

Keywords

USANA Health Sciences, USNA, G. Doug Iieking, CFO, Form 4, Stock Transactions, Restricted Stock Units, Beneficial Ownership